Dwight L. Evans

University of Pennsylvania, Philadelphia, PA, United States 
Biological Psychiatry
"Dwight Evans"
Mean distance: 16.13 (cluster 3)
Cross-listing: PsychTree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Spitsin S, Tebas P, Barrett JS, et al. (2017) Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults. Jci Insight. 2
Opondo PR, Ho-Foster AR, Ayugi J, et al. (2017) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. Aids and Behavior
Barrett JS, Spitsin S, Moorthy G, et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. Journal of Translational Medicine. 14: 148
Barrett JS, Bajaj G, McGuire J, et al. (2014) Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant. Current Hiv Research. 12: 121-31
Benton TD, Lynch KG, Dubé B, et al. (2013) The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replication. The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 51-7
Blume J, Douglas SD, Evans DL. (2011) Immune suppression and immune activation in depression. Brain, Behavior, and Immunity. 25: 221-9
Benton T, Lynch K, Dubé B, et al. (2010) Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication. Psychosomatic Medicine. 72: 925-32
Douglas SD, Cnaan A, Lynch KG, et al. (2008) Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. Aids Research and Human Retroviruses. 24: 375-8
Benton T, Staab J, Evans DL. (2007) Medical co-morbidity in depressive disorders. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 289-303
Dunlop BW, Crits-Christoph P, Evans DL, et al. (2007) Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology. 27: 614-9
See more...